Matti Nykter
Researcher Next ID · RN-039138
Researcher · Biochemistry, Genetics and Molecular Biology
Tampere University of Applied Sciences
Tampere, Finland
- Works count
- 481
- Citation count
- 15,717
- H-index
- 55
- i10-index
- 134
Research interests
Publications
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
Nature · 2022 · https://doi.org/10.1038/s41586-022-04975-9
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer
Nature Communications · 2021 · https://doi.org/10.1038/s41467-020-20493-6
Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease–Associated Colorectal Cancer
Gastroenterology · 2021 · https://doi.org/10.1053/j.gastro.2021.04.042
Immunogenomic Landscape of Hematological Malignancies
Cancer Cell · 2020 · https://doi.org/10.1016/j.ccell.2020.06.002
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer
European Urology · 2019 · https://doi.org/10.1016/j.eururo.2018.12.042
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
Cancer Discovery · 2018 · https://doi.org/10.1158/2159-8290.cd-17-0937
Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
Nature Communications · 2018 · https://doi.org/10.1038/s41467-018-03573-6
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer
European Urology · 2017 · https://doi.org/10.1016/j.eururo.2017.02.023
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
JNCI Journal of the National Cancer Institute · 2017 · https://doi.org/10.1093/jnci/djx118
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer
Clinical Cancer Research · 2017 · https://doi.org/10.1158/1078-0432.ccr-17-1140
Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
JAMA Oncology · 2016 · https://doi.org/10.1001/jamaoncol.2016.0494
Ageing-associated changes in the human DNA methylome: genomic locations and effects on gene expression
BMC Genomics · 2015 · https://doi.org/10.1186/s12864-015-1381-z
The evolutionary history of lethal metastatic prostate cancer
Nature · 2015 · https://doi.org/10.1038/nature14347
A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding
Nature Genetics · 2014 · https://doi.org/10.1038/ng.2862
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma
Journal of Clinical Investigation · 2013 · https://doi.org/10.1172/jci67144
Gene-pair expression signatures reveal lineage control
Nature Methods · 2013 · https://doi.org/10.1038/nmeth.2445
Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer
Cancer Cell · 2013 · https://doi.org/10.1016/j.ccr.2012.12.020
Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
PLoS ONE · 2011 · https://doi.org/10.1371/journal.pone.0017745
Function of C/EBPδ in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals
Nature Immunology · 2009 · https://doi.org/10.1038/ni.1721
Gene expression dynamics in the macrophage exhibit criticality
Proceedings of the National Academy of Sciences · 2008 · https://doi.org/10.1073/pnas.0711525105
Current projects
No projects listed.